Froedtert Hospital Launches Affiliation with Cleveland Clinic, Nation’s No. 1 Heart Hospital

Milwaukee, Wis. – Marking a first for the state, Froedtert & the Medical College of Wisconsin Froedtert Hospital and Ohio-based Cleveland Clinic will join forces in an affiliation that leverages the academic, clinical and research components of both organizations. This affiliation enables both organizations to share best practices related to patient care and hospital processes. … Read More

Cleveland Clinic Research Identifies Potential New Treatment for Asthma

Cleveland Clinic researchers have discovered a potential new remedy for the millions of asthma sufferers who are not responding to traditional treatments. In a study using asthmatic mice, researchers found that existing drugs designed to treat pulmonary arterial hypertension –or high blood pressure in the lungs – can combat asthma by opening airways and restoring … Read More

Update on Uterus Transplant Complications

Statement from Cleveland Clinic April 8, 2016 Preliminary results suggest that the complication was due to an infection caused by an organism that is commonly found in a woman’s reproductive system. The infection appears to have compromised the blood supply to the uterus, causing the need for its removal. There is an ongoing review of … Read More

For Post-Operative Atrial Fibrillation, Two Common Treatments – Rate Control and Rhythm Control – Show Equal Outcomes

Chicago — Cleveland Clinic researchers, as part of the Cardiothoracic Surgical Trials Network (CTSN), have found that two common approaches to post-operative atrial fibrillation – rhythm control and rate control – are equally safe and effective. Post-operative atrial fibrillation is the most common complication after cardiac surgery, occurring in 20 percent to 50 percent of patients … Read More

Final Stampede Results: Glycemic Benefits of Bariatric Surgery Persist Over Time

Chicago — In the final, five-year follow-up report from the influential STAMPEDE trial, Cleveland Clinic research shows that bariatric surgery’s beneficial effects on blood glucose control in mild and moderately obese patients with type 2 diabetes may persist for up to five years, with the advantage over diabetes medications-only approach widening over time. The five-year follow-up … Read More

Evacetrapib Impacts Cholesterol But Doesn’t Reduce Cardiovascular Events

Chicago — Cleveland Clinic researchers studying evacetrapib have shown that despite reducing levels of low-density lipoprotein (LDL, or “bad” cholesterol) by 37 percent and raising levels of high-density lipoprotein (HDL, or “good” cholesterol) by 130 percent, the drug failed to reduce rates of major cardiovascular events, including heart attack, stroke, angina or cardiovascular death. The phase … Read More

Statin Intolerance Objectively Identified in Patients

Chicago — In the first major trial of its kind, Cleveland Clinic researchers used a blinded rechallenge with atorvastatin or placebo to objectively confirm the presence of muscle-related symptoms in patients with a history of intolerance to multiple statins and found that evolocumab (a PCSK9 inhibitor) was a more effective option to lower cholesterol than ezetimibe … Read More